Table of Contents Table of Contents
Previous Page  767 / 812 Next Page
Information
Show Menu
Previous Page 767 / 812 Next Page
Page Background

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S349–S805

S763

until August 2015. The luck of improvement led to her admission.

We stopped antipsychotic treatments and prescribed her vitamin E

(900mg/day), clonazepam (6mg/day) and vitamin B6. The follow-

up led to the decline of the Abnormal Involuntary Movement Scale

(AIMS) score of 7 points over 6 weeks.

Conclusion

TD remains a serious side effect that worsens the

prognosis and affects the quality of life of patients. Cluster

randomised trial should be done in order to develop practice rec-

ommendations for prevention and management of TD.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.2282

EV1298

A psychiatrist’s poll on their methods

to treat schizoaffective disorder

L. Aguado

1 ,

, B. Girela

2

, P. Calvo

1

, J.E. Mu˜noz-Negro

1

,

J.A. Cervilla

1

1

San Cecilio University Hospital, Metal Health Unit, Granada, Spain

2

Santa Ana Hospital, Mental Health Unit, Motril, Spain

Corresponding author.

Introduction

Schizoaffective disorder (SAD) is the second most

frequent psychotic disorder after schizophrenia. There is a relative

scarcity of specific studies looking into SAD treatment and evidence

on drug treatment of SAD is patchy. We aimed to study naturalisti-

cally, interviewing psychiatrists systematically, what do they think

is most useful in SAD treatment.

Objectives/aims

To know the actual management of SAD in real

clinical practice and provided data for effective clinical studies.

Methods

We administered an online poll to 65 psychiatrists (52%

male, 48% female), 75% of which described themselves as having a

holistic background. The poll was completed using a Google doc’s

questionnaire. The three main questions made were:

– what is your first treatment choice for SAD;

– do you tend to use mono- vs. poly-therapy;

– provide a level of utility for each drug between 1 (little use) to 4

(maximum use).

Results

Atypical antipsychotics were considered the most com-

mon first choice in the treatment of SAD according to 66.2% of

psychiatrists. The second most selected first choice answer was

combining drugs and psychotherapy, which was answered by 20%

of the sample. Monotherapy was preferred (60%) to polytherapy

(40%). Finally, the most useful drug for SAD according to the sam-

ple was aripiprazole followed by mood stabilizers, olanzapine and

paliperidone.

Conclusions

Real practice in SAD treatment may differ grossly to

what is advocated for in clinical guidelines and seem to also deviate

from officially approved indications of some drugs.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.2283

EV1299

Erotomania: A case and review

A. Almada

, A. L

uengo , P. Casquinha , M.J. Heitor

Hospital Beatriz Ângelo, Psychiatry, Loures, Portugal

Corresponding author.

Introduction

Erotomania (“Clérambault’s syndrome”) is a rare

syndrome characterized by a delusional belief of being loved by

another person, usually of higher social status.

Objective

This case report aims to describe and discuss a case of

erotomania, providing an updated review on this disorder.

Methods

Regular clinical interviews were performed during

admission period to collect information about the clinical case and

to promote an intervention approach to the patient. A literature

review in Science Direct database, with the keyword “erotomania”,

was also conducted.

Results

A 51-year-old woman was admitted in Beatriz Ângelo

Hospital psychiatric ward with delusional beliefs of being loved

by the ex-boss. Positive misperceptions and persecutory delusions

regarding her husband as the obstacle for the love were mani-

fested. The lack of insight for the situation and the necessity of

treatment created some difficulties. A clinical report and a biblio-

graphic review were made to allow a better understanding about

the case and to orient the case evidence based.

Conclusions

Despite the evidence about the good response of

atypical antipsychotics (e.g. risperidone) in erotomania, in our case

study, the partial remission was only achieved with high dose of

the old typical antipsychotic, pimozide.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.2284

EV1300

Defining therapeutic plans and

purposes for psychiatric patients

served by a home-visiting program

F. Couto Gomes

, G. Sobreira , I. Capeto Coelho , J. Oliveira

Centro Hospitalar Psiquiátrico de Lisboa, Psychiatry, Lisbon, Portugal

Corresponding author.

Introduction

PreTrarCa is a home-visiting program at an in-

patient clinic in Lisbon, Portugal, constituted by a team of nurses,

social workers and a psychologist, and managed by a psychiatrist.

Objective

To describe the criteria and purposes for the home-

visiting program, its congruence with therapeutic plans, and

patients’ service satisfaction.

Aims

To help in defining common purposes to patients and pro-

fessionals, to improve quality of care.

Methods

Questionnaires regarding admission criteria and pur-

poses for the home-visiting, individualized therapeutic plans and

service satisfactionwere applied to patients, family, teammembers

and psychiatrists.

Results

As for the individual treatment plan, symptom con-

trol and better treatment adherence were frequently mentioned

by patients, family members, team members and psychiatrists

(respectively, 72.22% and 47.22%, 93.75% and 93.75%, 94,44% and

91.67%, and 68.42% and 33.33%). Team members frequently men-

tioned control of drug adverse effects (88.89%) and psychiatrists

frequently mentioned control of drug adverse effects, social inte-

gration and social skills (42.11%, 36.84%, 21.05%). As for the

purposes of home-visiting, symptom control and better treatment

adherence/administration of long acting injectable drugs were fre-

quently mentioned by the majority of patients, family members,

team members and psychiatrists (69.44% and 66.67%, 93.75% and

93.75%, 91.67% and 80.55%, 52.63% and 68.42%).

Conclusions

Patients, families, team members and psychiatrists

share similar views on the individual therapeutic plans, though

team members and psychiatrists give importance to some aspects

that patients and their families tend not to mention. Purposes are

generally congruent with treatment plans, which may signal satis-

factory communication between all these elements.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.2285